Mendus to participate in upcoming industry conferences
Press release Stockholm, Sweden, February 27, 2024 Mendus AB , a biopharmaceutical company focused on immunotherapies targeting tumor recurrence, today announced that it will participate in the...
Source: marketscreener.com